Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk

被引:88
作者
Ghassibe-Sabbagh, Michella [1 ]
Platt, Daniel E. [2 ]
Youhanna, Sonia [1 ]
Abchee, Antoine B. [3 ]
Stewart, Krista [4 ]
Badro, Danielle A. [1 ]
Haber, Marc [1 ]
Salloum, Angelique K. [1 ]
Douaihy, Bouchra [1 ]
el Bayeh, Hamid [1 ]
Othman, Raed [5 ]
Shasha, Nabil [5 ]
Kibbani, Samer [5 ]
Chammas, Elie [1 ]
Milane, Aline [1 ]
Nemr, Rita [1 ]
Kamatani, Yoichiro [6 ]
Hager, Joerg [7 ]
Cazier, Jean-Baptiste [8 ]
Gauguier, Dominique [8 ,9 ]
Zalloua, Pierre A. [1 ,10 ]
机构
[1] Lebanese Amer Univ, Sch Med, Beirut 11022801, Lebanon
[2] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA
[3] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon
[4] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA
[5] Rafic Hariri Univ Hosp, Div Cardiol, Beirut, Lebanon
[6] CEPH, F-75010 Paris, France
[7] CEA, Genom Inst, Ctr Natl Genotypage, F-91057 Evry, France
[8] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
[9] INSERM, UMRS872, Ctr Rech Cordeliers, F-75006 Paris, France
[10] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA
基金
英国惠康基金;
关键词
Homocysteine; Coronary artery disease (CAD); Diuretics; Lebanese population; Hypertension; Hyperhomocysteinemia; METHIONINE SYNTHASE REDUCTASE; CARDIOVASCULAR-DISEASE; SERUM HOMOCYSTEINE; VITAMIN THERAPY; POLYMORPHISMS; HYPERTENSION; HYPERHOMOCYSTEINEMIA; POPULATION; SEVERITY; CHINESE;
D O I
10.1016/j.atherosclerosis.2012.02.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Elevated levels of total plasma homocysteine are a risk factor for atherosclerotic disease. Aims: The rationale behind this study is to explore the correlation between degree and site of coronary lesion and hyperhomocysteinemia in Lebanese CAD patients and assess environmental and genetic factors for elevated levels of total plasma homocysteine. Methods: A total of 2644 patients were analyzed for traditional CAD risk factors. Logistic regression was performed to determine the association of hyperhomocysteinemia with degree and site of coronary lesions controlling for risk factors. Environmental and genetic factors for hyperhomocysteinemia were analyzed by logistic regression using a candidate gene approach. Results: Traditional risk factors were correlated with stenosis. Hyperhomocysteinemia associated with increased risk of overall stenosis, and risk of mild and severe occlusion in major arteries. Hyperhomocysteinemia and hypertension were highly correlated suggesting that hyperhomocysteinemia acts as a hypertensive agent leading to CAD. Diuretics and genetic polymorphisms in MTHFR and SLCO1B1 were associated with hyperhomocysteinemia. Conclusions: Hyperhomocysteinemia is a medical indicator of specific vessel stenosis in the Lebanese population. Hypertension is a major link between hyperhomocysteinemia and CAD occurrence. Genetic polymorphisms and diuretics' intake explain partly elevated homocysteine levels. This study has important implications in CAD risk prediction. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 30 条
  • [1] Predictors of coronary artery disease in the Lebanese population
    Abchee, A
    Puzantian, H
    Azar, ST
    Shbaklo, H
    Nasrallah, A
    Sawaya, FJ
    Alam, S
    Zalloua, PA
    [J]. THROMBOSIS RESEARCH, 2006, 117 (06) : 631 - 637
  • [2] Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals
    Clarke, Robert
    Halsey, Jim
    Lewington, Sarah
    Lonn, Eva
    Armitage, Jane
    Manson, JoAnn E.
    Bonaa, Kaare H.
    Spence, J. David
    Nygard, Ottar
    Jamison, Rex
    Gaziano, J. Michael
    Guarino, Peter
    Bennett, Derrick
    Mir, Fraz
    Peto, Richard
    Collins, Rory
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (18) : 1622 - 1631
  • [3] Dierkes J, 2007, VASC HEALTH RISK MAN, V3, P99
  • [4] Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms:: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid
    Emmanouil, SBA
    Berger, PB
    Ballman, KV
    Rozen, R
    [J]. ATHEROSCLEROSIS, 2003, 168 (02) : 315 - 322
  • [5] Humphries KH, 2003, CAN MED ASSOC J, V168, P1001
  • [6] Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study
    Jacques, PF
    Bostom, AG
    Selhub, J
    Rich, S
    Ellison, RC
    Eckfeldt, JH
    Gravel, RA
    Rozen, R
    [J]. ATHEROSCLEROSIS, 2003, 166 (01) : 49 - 55
  • [7] Genome-wide association meta-analysis for total serum bilirubin levels
    Johnson, Andrew D.
    Kavousi, Maryam
    Smith, Albert V.
    Chen, Ming-Huei
    Dehghan, Abbas
    Aspelund, Thor
    Lin, Jing-Ping
    van Duijn, Cornelia M.
    Harris, Tamara B.
    Cupples, L. Adrienne
    Uitterlinden, Andre G.
    Launer, Lenore
    Hofman, Albert
    Rivadeneira, Fernando
    Stricker, Bruno
    Yang, Qiong
    O'Donnell, Christopher J.
    Gudnason, Vilmundur
    Witteman, Jacqueline C.
    [J]. HUMAN MOLECULAR GENETICS, 2009, 18 (14) : 2700 - 2710
  • [8] Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians
    Kelemen, LE
    Anand, SS
    Hegele, RA
    Stampfer, MJ
    Rosner, B
    Willett, WC
    Montague, PA
    Lonn, E
    Vuksan, V
    Teo, KK
    Devanesen, S
    Yusuf, S
    [J]. ATHEROSCLEROSIS, 2004, 176 (02) : 361 - 370
  • [9] Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease - Evidence that all three MTHFR C677T genotypes confer different levels of risk
    Kluijtmans, LAJ
    Whitehead, AS
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 (04) : 294 - 299
  • [10] Köz C, 2009, ANATOL J CARDIOL, V9, P91